Literature DB >> 186079

The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin.

E B Smith, I B Massie, K M Alexander.   

Abstract

A large amount of plasma low density lipoprotein is present in human aortic intima, and this can be removed and measured by electrophoresis directly from the minced tissue into an antibody-containing gel. We now find that, in addition to this electrophoretically mobile lipoprotein, there is an immobilized lipoprotein fraction than can be released from lesions by incubation of the tissue sample with plasmin or other proteolytic enzymes after the mobile lipoprotein has been removed. The concentration of immobilized lipoprotein is highly correlated with the concentration of the residual cholesterol (not mobile on electrophoresis) that has accumulated in the tissue (r = 0.702; P less than 0.001). Thus, in normal intima and early gelatinous lesions it is about 15% of the concentration of mobile lipoprotein, whereas in the atheroma lipid layers of fibrous or gelatinous plaques it may be 2 or 3 times greater than the concentration of mobile lipoprotein. This suggests that immobilization of plasma lipoprotein is an intermediate step in the irreversible deposition of extracellular cholesterol in atherosclerotic lesions. Incubation with plasmin allowed maximum release of lipoprotein: plasmin = crude collagenase greater than trypsin greater than "pure" collagenase greater than chondroitinase ABC in order of their relative effectiveness. The concentration of immobilized lipoprotein was significantly correlated (r = 0.793; P less than 0.001) with the concentration in the tissue of fibrin or other insoluble derivatives of fibrinogen ("fibrin"). In aliquots of lesions incubated with varying amounts of plasmin for varying times there was a constant relation between release of lipoprotein and release of fibrin-degradation products. Together, these findings suggest that the lipoprotein is associated with insoluble "fibrin". This appears to be of considerable clinical interest, suggesting a synergism between lipoprotein and fibrinogen in the accumulation of lipid in lesions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186079     DOI: 10.1016/0021-9150(76)90049-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Fibrinogen/fibrin in atherogenesis.

Authors:  E B Smith; W D Thompson; L Crosbie; C M Stirk
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.

Authors:  Abigail S Haka; Inna Grosheva; Ethan Chiang; Adina R Buxbaum; Barbara A Baird; Lynda M Pierini; Frederick R Maxfield
Journal:  Mol Biol Cell       Date:  2009-10-07       Impact factor: 4.138

3.  Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries.

Authors:  A Niendorf; M Rath; K Wolf; S Peters; H Arps; U Beisiegel; M Dietel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell Formation.

Authors:  Abigail S Haka; Rajesh K Singh; Inna Grosheva; Haley Hoffner; Estibaliz Capetillo-Zarate; Harvey F Chin; Niroshana Anandasabapathy; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-20       Impact factor: 8.311

Review 5.  The vascular endothelium-pathobiologic significance.

Authors:  G Thorgeirsson; A L Robertson
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

6.  Lipoprotein and albumin accumulation in reendothelialized and deendothelialized aorta.

Authors:  D J Falcone; D P Hajjar; C R Minick
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

7.  Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis: purification and characterization of the antigen.

Authors:  K Nakagami; O Shimazaki; R Sato; Y Komine; S Ohkuma; T Takano
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

8.  TLR4 (Toll-Like Receptor 4)-Dependent Signaling Drives Extracellular Catabolism of LDL (Low-Density Lipoprotein) Aggregates.

Authors:  Rajesh K Singh; Abigail S Haka; Arky Asmal; Valéria C Barbosa-Lorenzi; Inna Grosheva; Harvey F Chin; Yuquan Xiong; Timothy Hla; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-10       Impact factor: 8.311

9.  The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.

Authors:  Tixieanna Dissmore; Cheikh I Seye; Denis M Medeiros; Gary A Weisman; Barry Bradford; Laman Mamedova
Journal:  Atherosclerosis       Date:  2016-07-29       Impact factor: 5.162

10.  Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.

Authors:  Abigail S Haka; Inna Grosheva; Rajesh K Singh; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.